Enhertu (fam-trastuzumab deruxtecan-nxki) is currently indicated as a second-line therapy for HER2-positive metastatic breast cancer.

AstraZeneca Plc (NASDAQ:AZN) on Monday released topline data from the DESTINY-Breast09 Phase 3 trial of Enhertu (5.4mg/kg) ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

Trastuzumab biosimilars saw significant market uptake in Japan after reimbursement incentives were implemented, but ...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply ...

Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer that’s spread or can’t be removed by surgery.

Trump said he wants to bring more drug manufacturing to the U.S. At a political fundraising dinner on Tuesday night, President Donald Trump said he plans to announce tariffs on pharmaceuticals soon.

EAU CLAIRE, Wis. (WEAU) - Last Thursday’s high speed chase and a drug bust the very next day that included 22 people getting arrested are in the words of Eau Claire police chief Matt Rokus ...

“Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug manufacturing back to the US while lamenting that other countries ...

This programme reviews and approves promising cancer drugs, helping patients to access treatments more quickly. As with any medicine, the MHRA will keep the safety and effectiveness of trastuzumab ...

Kennedy Jr. spoke with CBS News chief medical correspondent Dr. Jon LaPook about a range of topics, including measles, food additives and weight loss drugs. Here are some highlights from their ...